Entities / Company
Voyager Therapeutics (United States).
company in Cambridge, United States
- Reports this week
- 0
- Active events
- 1
- Connections
- 22
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Active this week
Gone quiet
No new reports in 90+ days-
Voyager Therapeutics participated in a conference in Boston, MA, on August 26, 2025, involving Baird and programs derived from the TRACER AAV platform.Some support2 reports
-
Voyager Therapeutics is expanding its Alzheimer's disease franchise with a program focused on modulating APOE using TRACER technology.Some support1 report
-
Voyager Therapeutics (United States) belongs to the biomedical and genetics industry.Some support1 report
No events began in the chosen period. Widen it, or reset.
Connections
The 1 strongest of 22, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Todd Carter Structural
Todd Carter holds the position of Chief Scientific Officer at Voyager Therapeutics.
History
Events by the month they beganJune 2026
4 events- Alfred W. Sandrock, Jr. was appointed as the Chief Executive Officer of Voyager Therapeutics on August 7, 2025.
- Voyager Therapeutics participated in a conference in Boston, MA, on August 26, 2025, involving Baird and programs derived from the TRACER AAV platform.
- Voyager Therapeutics is expanding its Alzheimer's disease franchise with a program focused on modulating APOE using TRACER technology.
- Voyager Therapeutics (United States) belongs to the biomedical and genetics industry.